Elizabeth A Moulton MD PhD
Pediatric Infections Associated with Transplant/Immunocompromised States
Physician
Join to View Full Profile
Baylor College of Medicine/Pediatric Infectious Diseases1102 Bates Ave., Room 1150Houston, TX 77030
Phone+1 832-824-4330
Dr. Moulton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Childrens HospitalFellowship, Pediatric Immunocompromised Infectious Disease, 2017 - 2018- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 2014 - 2017
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2011 - 2014
Washington University in St. Louis School of MedicineClass of 2011, MD, PhD
Certifications & Licensure
TX State Medical License 2018 - 2026
MA State Medical License 2014 - 2023
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season.Hannah Bahakel, Andrew J Spieker, Haya Hayek, Jennifer E Schuster, Lubna Hamdan
The Journal of Infectious Diseases. 2025-02-04 - 1 citationsImmunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients.Justin Z Amarin, Daniel E Dulek, Joshua Simmons, Haya Hayek, James D Chappell
Blood Advances. 2024-04-23 - 6 citationsThe Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Tra...Jennifer E Schuster, Lubna Hamdan, Daniel E Dulek, Carrie L Kitko, Einas Batarseh
Clinical Infectious Diseases. 2024-01-25
Press Mentions
- Adenovirus Remains a 'Strong Lead' for Unusual Hepatitis in Kids, CDC SaysMay 20th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
